Crossmark

A ‘mix and match’ approach to SARS-CoV-2 vaccination

Crossref DOI link: https://doi.org/10.1038/s41591-021-01463-x

Published Online: 2021-07-26

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deming, Meagan E.

Lyke, Kirsten E. https://orcid.org/0000-0002-4966-0830
License Information

Text and Data Mining valid from 2021-07-26

Version of Record valid from 2021-07-26
More Information

Article History

First Online: 26 July 2021

Competing interests

: K.E.L. is supported by funding from Pfizer (C4591001, site 1002).

Free to read: This content has been made available to all.